Healthy adult check-in for future infectious-disease volunteer studies
Part of Infections, Lungs & breathing clinical trials.
This study enrolls healthy adults to help set up future research studies about infectious diseases. If you qualify, you may be asked to join later “healthy volunteer” experiments and allow your samples to be stored for future research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 to 65 years old
- Generally have no significant health problems
- Be willing to join future healthy volunteer studies if invited
- If you are female: you must be post-menopausal, unable to become pregnant, or use effective birth control for the required time
- Be willing to let researchers store your samples for future studies
- No history of major medical conditions (like serious lung/heart disease, cancer, weakened immunity, seizures, or substance dependence)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how the body reacts to a specific flu virus (pH1N1) in a controlled setting. Healthy volunteers are exposed to the virus to help researchers understand the infection and test treatments. You will be monitored closely and given antiviral medication if needed.
This study tests how healthy adults respond to being exposed to a flu virus in a controlled setting. You will be closely monitored and may help researchers learn more about flu and potential treatments.
This study looks at how the flu spreads from one person to another. Healthy volunteers will be exposed to flu from natural donors while staying in a facility, so researchers can learn more about transmission and help prevent future outbreaks.
This study looks at how your immune system (your body’s infection-fighting system) responds during and around the time of a flu illness. It’s meant to help researchers better understand immune changes in healthy adults and may guide future flu care.
This study tests a new drug, RLX-2508-102, in healthy people to see how safe it is and how the body handles it. It's an early step to learn if the medicine could be used for future treatments.
This study looks at flu-like symptoms and other respiratory infections in adults in Lusaka, Zambia. It aims to understand how these infections affect people with and without HIV, and may help improve care.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.